Aceragen | Lånekapital

Loan Capital Lave om Dato
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amgen USD 63.17B 4.13B 2023-12
Clal Biotechnology ILS 7.49M 405K 2022-12
Compugen USD 0 0 2022-06
CSL USD 11.17B 269.8M 2023-06
Dynavax Technologies USD 222.7M 283K 2023-12
Eli Lilly USD 17.92B 956.9M 2023-09
Gilead Sciences USD 23.19B 1.98B 2023-09
GlaxoSmithKline GBP 15.99B 440M 2023-09
Grifols EUR 10.3B 926.47M 2023-09
Pfizer USD 61.05B 308M 2023-09
Roche Holding CHF 20.35B 1.05B 2023-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06



Aceragen Lånekapital - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.